Coastal Investment Advisors, Inc. Novo Nordisk A S Transaction History

Coastal Investment Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	SELL	$49.46 - $64.78 $15,184 - $19,887	-307 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$49.86 - $58.26 $2,044 - $2,388	-41 Reduced 11.78%	307 $18,000
Q3 2019 Oct 18, 2019	BUY	$47.54 - $53.43 $4,088 - $4,594	86 Added 32.82%	348 $18,000
Q2 2019 Aug 01, 2019	BUY	$46.79 - $52.47 $1,544 - $1,731	33 Added 14.41%	262 $14,000
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $10,616 - $12,052	229 New	229 $12,000

1,928

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $178B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.